Get Your Personalized Supplement StackSupplement Stack Quiz

Rauwolfia Vomitoria Extract

Also known as: Rauwolfia vomitoria, African snake root, Devil pepper

Overview

Rauwolfia vomitoria is a plant species belonging to the Apocynaceae family, native to tropical Africa. It has a history of traditional use in folk medicine for various health conditions. The plant is characterized by its rich content of monoterpene indole alkaloids (MIAs), such as ajmaline and ajmalicine, which are known for their pharmacological properties, including CNS depressive and hypotensive effects. Traditionally, it has been used to treat central nervous system (CNS) disorders, cardiovascular diseases, and as an antidote. Modern research explores its potential in treating cancer, erectile dysfunction, and other conditions. The plant's extracts and alkaloids are available in various forms, including capsules and teas, though the specific formulation can affect bioavailability and efficacy. Research on Rauwolfia vomitoria is moderately advanced, with several studies on its pharmacological properties and traditional uses, but more clinical trials are needed to fully establish its efficacy and safety.

Benefits

Rauwolfia vomitoria extract has demonstrated antitumor activity, particularly against ovarian cancer cells, by inhibiting cell growth and inducing apoptosis. Studies show that combining the extract with carboplatin significantly enhances the antitumor effect, reducing tumor burden by 87-90% and ascites volume by 89-97%. The extract also exhibits antioxidant properties and inhibits enzymes related to erectile dysfunction, such as acetylcholinesterase (AChE), arginase, and angiotensin-converting enzyme (ACE). Traditionally, Rauwolfia vomitoria has been used for cardiovascular diseases, with some studies suggesting cardioprotective effects due to its alkaloid content. Its CNS effects have also been explored, though modern clinical evidence is limited. These benefits make it a potential adjunct therapy for cancer patients and those with erectile dysfunction.

How it works

Rauwolfia vomitoria exerts its effects through several biological pathways. Its antitumor activity is primarily attributed to the induction of apoptosis in cancer cells. Additionally, the extract inhibits enzymes such as AChE, arginase, and ACE, which contributes to its potential benefits in treating erectile dysfunction. The alkaloids in Rauwolfia vomitoria interact with the CNS, exerting depressive and hypotensive effects. Its cardioprotective effects are likely due to the interaction of its alkaloids with the cardiovascular system. The extract's known molecular targets include AChE, arginase, ACE, and cellular targets involved in apoptosis induction in cancer cells. While the bioavailability of its alkaloids is not extensively studied, in vivo effects suggest that the compounds are absorbed and active in the body.

Side effects

The safety profile of Rauwolfia vomitoria is not fully established, and caution is advised due to the presence of potent alkaloids. Traditional use suggests potential CNS depressive effects and hypotension. Specific uncommon and rare side effects are not well-documented in the available literature, but the potent nature of its alkaloids suggests the potential for severe adverse effects if not used correctly. Rauwolfia vomitoria may interact with CNS depressants, antihypertensive drugs, and other medications due to its pharmacological properties. Contraindications include conditions where CNS depression or hypotension would be harmful, such as severe depression, hypotension, or certain cardiovascular conditions. Caution is advised in pregnant or breastfeeding women, children, and individuals with severe medical conditions due to the lack of comprehensive safety data.

Dosage

The minimum effective dose of Rauwolfia vomitoria is not well-established, but in vitro and in vivo studies have used doses ranging from 20 to 50 mg/kg in animal models. Optimal dosages are not clearly defined and require further clinical trials to establish safe and effective ranges. The maximum safe dose is also not established, and caution is advised due to the potent nature of its alkaloids. Timing considerations are not well-defined and would depend on the specific application and clinical context. Extracts are commonly used, but the form (e.g., capsules, teas) and preparation method can affect bioavailability and efficacy. Absorption factors are not extensively studied, but the presence of alkaloids suggests that they may be absorbed systemically. There is no clear evidence on required cofactors for the efficacy of Rauwolfia vomitoria extract.

FAQs

Is Rauwolfia vomitoria safe to use?

Rauwolfia vomitoria should be used with caution due to its potent alkaloids and potential interactions with other medications. Consult a healthcare professional before use.

How should Rauwolfia vomitoria be administered?

The timing and administration should be guided by healthcare professionals due to the lack of comprehensive dosing guidelines. Follow their recommendations carefully.

What results can I expect from using Rauwolfia vomitoria?

Expected results vary depending on the application, but significant antitumor and enzyme inhibitory effects have been observed in studies. Results may vary.

Can Rauwolfia vomitoria replace medical treatment?

No, it is not a substitute for medical treatment and should be used under the guidance of a healthcare professional. It should be used as a complementary therapy.

Research Sources

https://pubmed.ncbi.nlm.nih.gov/24465036/ – This in vitro and in vivo study demonstrated that Rauwolfia vomitoria extract exhibits potent antitumor activity against ovarian cancer cells. The extract inhibited cell growth and induced apoptosis, and when combined with carboplatin, it significantly enhanced the antitumor effect, reducing tumor burden and ascites volume in a mouse model. This suggests that Rauwolfia vomitoria could be a potential adjunct therapy for ovarian cancer.
https://pubmed.ncbi.nlm.nih.gov/37216495/ – This in vitro study investigated the chemical composition, antioxidant, and enzyme inhibitory properties of Rauwolfia vomitoria extract. The extract was found to inhibit enzymes such as acetylcholinesterase (AChE), arginase, and angiotensin-converting enzyme (ACE), and it also exhibited antioxidant properties. These findings suggest potential benefits for treating erectile dysfunction and other conditions related to enzyme activity.
https://www.rjpharmacognosy.ir/article_162844_9294b8a17923b8be94eaf1c529052283.pdf – This systematic review provides a comprehensive overview of the traditional uses, phytochemistry, and pharmacological properties of Rauvolfia species, including Rauwolfia vomitoria. The review highlights the plant's traditional uses in treating CNS disorders and cardiovascular diseases, as well as its rich content of alkaloids with various pharmacological activities. It serves as a valuable resource for understanding the plant's potential therapeutic applications.
https://pubmed.ncbi.nlm.nih.gov/35504505/ – This study investigates the effects of Rauwolfia vomitoria on multidrug resistance in cancer cells. The findings suggest that Rauwolfia vomitoria may have the potential to overcome drug resistance in certain cancer treatments, enhancing the efficacy of chemotherapy. This could be a significant advancement in cancer therapy, particularly for cancers that develop resistance to conventional treatments.
https://journals.sagepub.com/doi/abs/10.1177/1534735414532010 – This study examines the use of Rauwolfia vomitoria in traditional African medicine for the treatment of hypertension. The research provides insights into the plant's historical use and its potential mechanisms of action in reducing blood pressure. It supports the traditional claims and provides a basis for further scientific investigation into its antihypertensive properties.